COMMUNIQUÉS West-GlobeNewswire
![GlobalNewswire](/sites/santelog.com/www.santelog.com/themes/santelog/images/nasdacinner.png)
-
Receipt of Nasdaq Delisting Determination - Plans to Appeal
30/08/2024 - 22:30 -
Jushi Holdings Inc. Announces Filing of Canadian Preliminary Base Shelf Prospectus
30/08/2024 - 22:30 -
Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
30/08/2024 - 22:30 -
Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to October 3, 2024
30/08/2024 - 22:35 -
Alignment Health Plan Ranks No. 2 in Customer Satisfaction Among Medicare Advantage Plans in California in J.D. Power Study
29/08/2024 - 14:00 -
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
29/08/2024 - 14:00 -
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
29/08/2024 - 14:00 -
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
29/08/2024 - 14:00 -
ORYZON to Provide Corporate Progress Updates at Several Events in September
29/08/2024 - 14:14 -
Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical Studies
29/08/2024 - 14:15 -
Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking
29/08/2024 - 14:30 -
BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family
29/08/2024 - 14:30 -
Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations
29/08/2024 - 14:30 -
Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution
29/08/2024 - 14:30 -
Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference
29/08/2024 - 14:30 -
The International Myeloma Foundation (IMF) Brings Back ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2024
29/08/2024 - 14:45 -
Psychemedics Corporation Launches New Ketamine Hair Testing Service
29/08/2024 - 15:00 -
Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® Label
29/08/2024 - 15:00 -
Biomerica Reports Fiscal 2024 Year End Results
29/08/2024 - 15:00
Pages